By proceeding, you agree to our Terms of Use and Privacy Policy.
Secretary General
#pharmaceuticalindustry #biotechnology #hta #pharma #biotech #orphandrugs #rarediseases
#Europe
Alexander Natz is secretary-general of the European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) in Brussels.
Global Head of Digital Clinical Trials Solutions
#strategy #telehealth #rarediseases #virtualtrials
#Northamerica
Over 25 years experience as a Strategic Advisor and Business Developer focused on transforming clinical development for the patient, site and pharmaceutical companies utilizing innovative solutions an
Chief Scientific Officer
#rarediseases #eeg
#NorthAmerica
Cross-Functional Drug Discovery and Development Program and Team Leader with 20 years of discovery, preclinical, clinical and biopharma management experience in biotech startups through global pharma.
Director, Global Medical Affairs
#medicalaffairs #nephrology #rarediseases
Director, Global Medical Affairs with experience in early and late stage clinical development. Extensive nephrology research experience in novel drug target validation, GPCRs, cell signaling and rare
Senior Director of Global Patient Advocacy at uniQure
#genetherapy #rarediseases #biotechnology #patientadvocacy #huntingtonsdisease
Passionate patient advocate working with patient communities to make the next generation of therapies a reality.
Visiting Researcher
#advocacy #healthlaw #orphandrugs #rarediseases #andglobalhealthcare
#SouthAmerica
Daniel is currently working as a Visiting Researcher at Georgetown University
Vice President & US Country Head, Public Affairs & Patient Advocacy
#rarediseases #hemophilia #oncology #transplant #diabetes #cardiovascular #neurology #immunology
In my role, I am fortunate to partner with leaders in the U.S. advocacy community as we work together to improve patients’ access to innovative medicines and vaccines.
Senior Vice President Commercial Strategy & Operations
#RareDiseases #PLmanagement #Leadership
Driven to make an impact for patients and their caregivers affected by rare and ultra-rare diseases – from early detection to therapeutic intervention.
Executive Board Member
#rarediseases #immunotherapy #immunooncology #covid19research #pharmaceuticalmedicine
Entrepreneurial seasoned executive, strategic leader across all stages of product development, licensure and commercialization. Therapeutic focus for over 20 years in oncology (immune therapeutics, bi
Executive Director, Patient Advocacy & Scientific Engagement
#patientadvocacy #rarediseases #genetherapy
Voice of the Patient: Interprets and Promotes the voices of patients and families dealing with rare and inherited diseases from "bench to bedside" - from pre-clinical development through commercializa
Global Head, RNA Emerging Science Lead
#biotechnology #liverdisease #rarediseases
John is a Data-driven drug discovery leader and RNA biologist turned S&E scout. Broad experience in nucleic acid therapeutics and genetic medicines.
Chief Medical Officer
#rarediseases #nephrology #medicalaffairs
Dr. Inrig is the Chief Medical Officer at Travere Therapeutics with a focus on innovating and delivering novel therapies for patients and their families with rare diseases. Dr.